Paxlovid Being Distributed on NYC Streets Despite Rebound Phenomenon

Paxlovid,  the antiviral Covid drug authorized for emergency use by the Food and Drug Administration (FDA), has been touted by Pfizer as a treatment for coronavirus even though several studies have shown its effectiveness  is not what the pharmaceutical giant claims. In fact, Pfizer discontinued its own study after it was discovered Paxlovid worked well for patients over 65 but didn&rsquo;t work well for heathier patients who had contracted the Covid-19 virus. Pfizer&rsquo;s own study demonstrated that Paxlovid failed to show a benefit as a preventative therapy. However, that didn&rsquo;t stop the company from praising the medication as a viable treatment. The hype appears to have paid off.
New York City Giving Out Paxlovid to Covid Positive Cases